Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03644472Phase 2Completed
Phase 2, randomised, double-blind trial (2 arms), sponsored by The Pennsylvania State University. Primary endpoints: Macro-vascular reactivity at Day 8 and Micro-vascular reactivity at Day 8. Started Nov 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03644472.